| Literature DB >> 18504100 |
V van Weel1, R B van Tongeren, V W M van Hinsbergh, J H van Bockel, P H A Quax.
Abstract
Stimulation of vascular growth to treat limb ischemia is promising, and early results obtained from uncontrolled clinical trials using angiogenic agents, e.g., vascular endothelial growth factor, led to high expectations. However, negative results from recent placebo-controlled trials warrant further research. Here, current insights into mechanisms of vascular growth in the adult, in particular the role of angiogenic factors, the immune system, and bone marrow, were reviewed, together with modes of its therapeutic stimulation and results from recent clinical trials. Three concepts of vascular growth have been described to date-angiogenesis, vasculogenesis, and arteriogenesis (collateral artery growth)-which represent different aspects of an integrated process. Stimulation of arteriogenesis seems clinically most relevant and has most recently been attempted using autologous bone marrow transplantation with some beneficial results, although the mechanism of action is not completely understood. Better understanding of the highly complex molecular and cellular mechanisms of vascular growth may yet lead to meaningful clinical applications.Entities:
Mesh:
Substances:
Year: 2008 PMID: 18504100 DOI: 10.1016/j.avsg.2008.02.017
Source DB: PubMed Journal: Ann Vasc Surg ISSN: 0890-5096 Impact factor: 1.466